SMMTSummit Therapeutics Inc.
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−5% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −5% vs its 200-day average.
Moderately shorted, settled Sep 30, 2026, about a week of normal trading to cover. Level with the previous count, up from 5.0% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How SMMT is trading
Summit Therapeutics Inc. is −30% over the past year while the S&P 500 is +16%: 46 points behind the market. Through the fall, its own insiders bought $104M more stock than they sold.
1-year return · S&P 500 +16%
- vs 200-day average
- −5.3%
vs 200-day average · below trend, but not far
- RSI (14)
- 38
RSI (14) · neutral
- Below its 52-week high
- 41%
Below its 52-week high
Details›
- Last close2026-10-23
- $15.46
- 1 monthS&P 500 −0.94%
- −5.6%
- 1 yearS&P 500 +16%
- −30%
- 5 yearsS&P 500 +86%
- +198%
- vs 50-day average$15.78
- −2.0%
- 52-week high
- $26.38
- 52-week low
- $12.42
- Annualised volatility
- 86%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-22
- $104M
| Year | Return |
|---|---|
| 2026 (year to date) | −12% |
| 2025 | −2.0% |
| 2024 | +584% |
| 2023 | −39% |
| 2022 | +58% |
| 2021 | −43% |
| 2020 | +194% |
| 2019 | +39% |
| 2018 | −90% |
| 2017 | +29% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +12% |
| Feb | 10 | 5 of 10 | +6.4% |
| Mar | 10 | 4 of 10 | +4.2% |
| Apr | 10 | 5 of 10 | +2.1% |
| May | 10 | 6 of 10 | +11% |
| Jun | 10 | 3 of 10 | −11% |
| Jul | 11 | 6 of 11 | +5.5% |
| Aug | 11 | 6 of 11 | +0.81% |
| Sep | 11 | 5 of 11 | +11% |
| Oct | 11 | 3 of 11 | −5.3% |
| Nov | 10 | 3 of 10 | −2.1% |
| Dec | 10 | 4 of 10 | +38% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.